New Key Statistics Module, Z-Score and F-Score
NSE:TORNTPHARM Key Ratios
Market Cap ₹ M | 879,924.30 |
Enterprise Value ₹ M | 915,374.30 |
P/E(ttm) | 58.87 |
PE Ratio without NRI | 62.47 |
Forward PE Ratio | 42.92 |
Price/Book | 13.12 |
Price/Sales | 8.53 |
Price/Free Cash Flow | 49.04 |
Price/Owner Earnings | 54.73 |
Payout Ratio % | 0.53 |
Revenue (TTM) ₹ M | 103,186.00 |
EPS (TTM) ₹ | 44.16 |
Beneish M-Score | -2.65 |
10-y EBITDA Growth Rate % | 11.60 |
5-y EBITDA Growth Rate % | 10.90 |
y-y EBITDA Growth Rate % | 47.30 |
EV-to-EBIT | 36.12 |
EV-to-EBITDA | 27.49 |
PEG | 5.73 |
Shares Outstanding M | 338.45 |
Net Margin (%) | 14.48 |
Operating Margin % | 23.41 |
Pre-tax Margin (%) | 20.88 |
Quick Ratio | 0.62 |
Current Ratio | 1.08 |
ROA % (ttm) | 10.43 |
ROE % (ttm) | 23.60 |
ROIC % (ttm) | 13.74 |
Dividend Yield % | 1.15 |
Altman Z-Score | 7.87 |
NSE:TORNTPHARM Number of Guru Trades
NSE:TORNTPHARM Volume of Guru Trades
Gurus Latest Trades with NSE:TORNTPHARM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NSE:TORNTPHARM is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data